Related Experiment Video

Updated: Jun 20, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Switching to long-acting anti-retroviral therapy with no baseline resistance data: is there value in proviral DNA

Colin Fitzpatrick1,2, Claire Norcross1,2,3, Lena Paul1

  • 1The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.

International Journal of STD & AIDS
|June 18, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Related Experiment Videos

Last Updated: Jun 20, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Articles linked to this work by shared authors, journal, and citation graph.

Baseline HIV genotypic resistance testing in patients newly diagnosed with HIV: When do we need to consider baseline integrase resistance testing for everyone?

HIV medicine·2026

Long-Acting HIV Therapy in African Adults with Adherence Challenges.

The New England journal of medicine·2026

Participant experiences of stopping ART as part of a clinical trial; findings from a qualitative study within the RIO trial in the United Kingdom.

HIV research & clinical practice·2026

A Novel 2-Hz Coronary Intravascular Lithotripsy Catheter for Calcified Coronary Artery Disease: One-Year Outcomes of the DISRUPT CAD Duo Trial.

The American journal of cardiology·2026

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial.

Nature medicine·2026

The Transfer Advantage: Regional Chest Wall Care Without Delay.

The American surgeon·2026

Asymptomatic extragenital Neisseria gonorrhoeae infection among transgender women in Argentina: Prevalence, antimicrobial susceptibility, and molecular characterization.

International journal of STD & AIDS·2026

Genomic diversity and antimicrobial resistance determinants among publicly available Mycoplasma genitalium genomes: a comparative phylogenomic analysis.

International journal of STD & AIDS·2026

Perception and practice of herbal medicine use among people living with HIV in Bushenyi health Centre IV, Western Uganda.

International journal of STD & AIDS·2026

HIV-1 diagnosis during pre-exposure prophylaxis: A case report.

International journal of STD & AIDS·2026

Recommendations for HIV care continuity during droughts and floods with key populations living with HIV in Kampala, Uganda: Qualitative insights.

International journal of STD & AIDS·2026

Field Performance and usability of a novel molecular point-of-care assay for Chlamydia trachomatis and Neisseria gonorrhoeae detection.

International journal of STD & AIDS·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us